We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




MRI-Guided Breast Biopsy Now Mainstream

By HospiMedica staff writers
Posted on 20 Mar 2006
Clinicians and radiologists at a breast MRI conference in Puerto Vallarta (Mexico) in March 2006 agreed that MRI is now considered mainstream for high-risk women, especially the use of MRI-guided breast biopsy.

"MRI is showing us pathology that was known, but we just couldn't image it before,” said Elizabeth Morris, M.D., associate professor of radiology and director of breast MRI at Memorial Sloan-Kettering Cancer Center in (New York, NY, USA). More...


Suros Surgical Systems, Inc. (Indianapolis, IN, USA), a developer of medical devices, has created a system called Atec that can perform a 30-minute MRI-guided vacuum-assisted breast biopsy. More than 8,000 MRI-guided breast biopsy procedures have been successfully performed using the MRI Atec system since May 2003. Suros received European CE Mark approval in November 2005, clearing the way for commercial availability of the Atec system in the European Union.

Dr. Morris observed that existing clinical studies support the significant role that breast MRI plays in screening the high-risk population and staging patients with a recent breast cancer diagnosis. In at least three recent clinical studies of MRI-guided breast biopsy using the Suros Atec system, results showed a 96%, 98%, and 100% technical success rate of targeting and acquiring suspect tissue with a total average procedure time of 35 minutes, including scans.

"These were some of the first patients who had MRI-guided vacuum assisted breast biopsy,” stated Connie Lehman, M.D., Ph.D., director of breast imaging at the University of Washington Medical Center (Seattle, USA). "Since then, procedure times have been reduced even more. As MRI is increasingly applied to screen high-risk women, safe, minimally invasive, and efficient techniques of MRI-guided biopsy are essential for MRI to be effective in detecting cancer earlier in this patient population.”


Related Links:
Suros Surgical Systems

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Silver Member
ECG Management System
NEMS Web
Isolation Stretcher
IS 736
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.